Washington: A bipartisan group of 117 lawmakers has urged the US Food and Drug Administration (FDA) to crack down on companies, primarily based in Europe, that ship chemical abortion drugs from India to the US.
These European companies, like Aid Access, are circumventing the FDA’s safety requirements and placing the lives of women and their children at risk, the lawmakers said in a letter to Norman Sharpless, the Acting FDA Commissioner.
In the letter dated May 10, the bipartisan group of Congressmen urged Sharpless to crack down on Aid Access and Rablon, two foreign companies known to distribute Mifeprex, a chemical abortion drug, by mail-order to US customers in violation of the FDA’s safety protocols.
